The Endpoint Outcomes team will be presenting at the ISPOR 20th Annual International meeting in Philadelphia (May 16-20). Brooke Witherspoon will be presenting at a workshop entitled: Development and Communication since the Issuance of the FDA’s Guidance to Industry on Patient Reported Outcomes: Then and Now. Chris Evans has several posters in the areas of diabetes, COPD, eosinophilic esophagitis and triple negative breast cancer. Chris’ work represents Endpoint Outcomes’ work in the area of ePRO methodology and PRO labeling claims in upper GI disorders.